To be launched on Aug 2015
 
Sponsored by Biophysical Society of China and Institute of Biophysics, CAS, P.R. China.
Online published by SpringerLink.
  Links


 
     Author Guidelines
 

AUTHOR GUIDE & POLICIES  Download PDF


INTRODUCTION
1. ABOUT BIOPHYSICS REPORTS
1.1 MISSION STATEMENT
BIOPHYSICS REPORTS, as the official journal of Biophysical Society of China, is an international open-accessed journal for the publication of novel theories, methods, protocols and significant improvements to basic research techniques in multidisciplinary areas of biological and biomedical sciences.
BIOPHYSICS REPORTS aims to publish the highest quality work representing novel research approaches to life sciences. Articles should be of sufficient impact to be of general interest to life scientists, regardless of their research specialty.
At BIOPHYSICS REPORTS, our goal is to accelerate scientific advancement by making new research approaches available quickly and openly. We make data more accessible and more useable. We aim to create a BPRoader audience for important discoveries, and to make BIOPHYSICS REPORTS one of the best choice journals for all researchers, in particular for methodology/biotechnology researchers.
1.2 SCOPE
BIOPHYSICS REPORTS welcomes submission of papers reporting methods and/or techniques involved but not limited in the areas of in biophysics, cell biology, immunology, memBPRane biology, redox biology, photobiology, neuroscience & computational neuroscience, oncology, biochemistry, biomechanics & mechanobiology, structural biology, molecular imaging, electron microscopy, computational biology, bioinformatics, nanobiophysics & nanobiotechnology, genetics, model organisms, protein science, developmental biology, bioimaging, omics.
BEFORE YOU BEGIN
2. GENERAL POLICIES
2.1 ETHICS IN PUBLISHING
The BPR will not tolerate plagiarism in submitted manuscripts. Passages quoted or closely paraphrased from other authors (or from the submitting authors' own published work) must be identified as quotations or paraphrases, and the sources of the quoted or paraphrased material must be acknowledged. Use of unacknowledged sources will be construed as plagiarism. If any manuscript is found to contain plagiarized material, the peer-review process will be halted immediately. For information on Ethics in publishing and Ethical guidelines for journal publication, please refer to the links below:
Council of scientific editors
http://www.councilscienceeditors.org/i4a/pages/index.cfm?pageid=3331
COPE
http://www.publicationethics.org/files/International%20standards_authors_for%20website_11_Nov_2011.pdf
2.2 BPR’S POLICY ON DUPLICATE PUBLICATION
Manuscripts submitted to BPR must be original and not published or submitted for publication elsewhere. This rule applies to manuscripts previously submitted to BPR, as well as material submitted elsewhere while BPR is considering the contribution.
If any part of the contribution that an author wishes to submit to BPR has appeared or will appear elsewhere, the author must specify the details in the covering letter accompanying the submission.
BPR is happy to consider submissions containing material that has been published previously in the form of an abstract or as part of a published lecture or academic thesis which has been published according to the requirements of the institution awarding the qualification.
BPR allows prior publication on recognized community preprint servers (such as ArXiv) for review by other scientists in the field before formal submission to the journal. The details of the preprint server concerned and any accession numbers should be included in the cover letter accompanying submission of the manuscript to BPR. This policy does not extend to preprints available to the media or that are otherwise publicised outside the scientific community before or during the submission and consideration process at BPR.
All in-press or submitted works that are pertinent to the manuscript under consideration by the journal (including those cited in the manuscript under consideration) must accompany the submission. Related manuscripts that have been submitted elsewhere during the period of revision and any information that will aid in the review process must accompany revised manuscripts. Failure to provide copies of related manuscripts under consideration elsewhere may delay the review process and may be grounds for rejection.
Under no circumstances will any paper be considered that contains any data that have been submitted for publication elsewhere.
If an author of a submission is re-using figure(s) published elsewhere, or that is copyrighted, the author must provide documentation that the previous publisher or copyright holder has given permission for the figure to be re-published. The editors of BPR consider all material in good faith that the journal has full permission to publish every part of the submitted material, including illustrations.
2.3 HANDLING OF PAPERS
All submissions are initially evaluated in depth by a team of scientific editors. Papers that are not deemed by the editors to be strong candidates for publication will be returned to the authors without detailed review, typically within 1–7 days. Otherwise, manuscripts will be sent to reviewers who have agreed to assess the paper rapidly. The editors will make every effort to reach decisions on these papers within 2–3 weeks of the submission date. If revisions are a condition of publication, editors will carefully evaluate the reviewers' comments and, whenever possible, will provide guidance on the important concerns to be addressed. We generally allow 3 months for revisions and consider only one revised version of the paper. Evaluations of conceptual advance and significance are made based on the literature available on the day of the final decision, not the day of submission. Accepted papers will be published in print within 2 months of acceptance and, in most cases, earlier in print or online. Any major changes after acceptance are subject to review and may delay publication.
2.4 AUTHORSHIP
The co-authors of a paper should include all persons who have made significant scientific contributions to the reported work and who share responsibility and accountability for it. Inclusion of a name as an author is a statement that this person did make substantial contributions. Other contributors should be indicated in the Acknowledgments section.
The corresponding author(s) is responsible for ensuring that all appropriate contributors are listed as authors and that all authors have agreed to the manuscript's content and its submission to BPR. All authors will be notified that the paper has been submitted. To ensure acknowledgment of submission, current email addresses must be provided for all authors on the paper. The corresponding author(s) is also responsible for ensuring adherence to all editorial and submission policies and informing all co-authors of any matters arising and to deal promptly with such matters.
Equal contribution designations are only permitted for the first author position. There is no limitation on the number of first authors that can be designated as equal contributors.
Authors are welcome to suggest suitable independent reviewers when they submit their manuscripts, but these suggestions may not be followed by the journal. Authors may also request the journal to exclude a few (usually not more than two) individuals or laboratories. The journal sympathetically considers such exclusion requests and usually honours them, but the editor's decision on the choice of peer-reviewers is final.
2.5 COPYRIGHT
The Biophysics Reports is published by the Editorial Office on behalf of the Biophysical Society of China, the sole owner of the journal. Upon acceptance of an article, authors will be asked to transfer copyright. This transfer will ensure the widest possible dissemination of information. A COPYRIGHT TRANSFER STATEMENT will be provided with the letter of acceptance of the manuscript.
Authors are asked to scan and return by e-mail the signed statement to the editorial office of BPR editorial office.
2.6 CONFLICT OF INTEREST
BPR requires all authors to disclose any actual or potential conflict of interest that might be construed to influence either the results or the interpretation of their manuscript, such as financial, personal or other relationships with other people or organizations with related interests. Authors must declare such conflicts both in the cover letter and in the COMPLIANCE WITH ETHICS GUIDELINES section of the manuscript itself. This policy applies to all submitted manuscripts and review materials.
2.7 HUMAN AND ANIMAL RIGHTS
Manuscripts describing any experimental work with humans should include a statement that the research has been carried out in accordance with the Declaration of Helsinki (2013) of the World Medical Association. Authors should confirm that the Ethical Committee of the Institution in which the work was performed has approved it, and that the subjects have been given informed consent to the work.
Experiments involving animals should be performed in accordance with relevant institutional and national guidelines and regulations and a statement to this effect must also be included. In the manuscript, a statement identifying the committee approving the experiments and confirming that all experiments conform to the relevant regulatory standards must be included in the COMPLIANCE WITH ETHICS GUIDELINES section. For additional information on the reporting of work in animals, please refer to the ARRIVE Guidelines.
2.8 DATABASES
Sequences of nucleic acids and proteins, molecular structures from X-ray crystallography and NMR, as well as molecular models, electron microscopic reconstructions, and microarray data should be deposited in the appropriate database prior to publication. These data must be accessible without restriction upon publication of the submitted paper. Entry names or accession numbers must be included in the paper before its publication. Microarray data must be MIAME compliant.
2.9 LANGUAGE
All submitted papers should be written in clear, proper English. Authors who are not native English speakers may ask an English-speaking colleague to proofread your paper. Papers that fail to meet basic standards of literacy are likely be declined immediately by the editors.
2.10 SUBMISSION
https://mc03.manuscriptcentral.com/bpr
PREPARATION
3. SUBMISSION REQUIREMENTS
3.1 ORIGINAL RESEARCH PAPERS
Cover letter
A cover letter from the corresponding author must accompany the manuscript and should provide a brief description of what was known in the field, the conceptual breakthrough, and the significance of the reported findings. The authors are encouraged to suggest appropriate reviewers and are permitted to make request for reviewer exclusions. The cover letter should state that the submitted material is original research, has not been previously published, and has not been submitted elsewhere while under review by Biophysics Reports. The cover letter is confidential and will not be sent to the reviewers.
Manuscript components
Manuscript should be arranged in the following order: (a) Title section, including Title, Running Title, Keywords, Authors, Author Affiliations, and Correspondence. (b) Abstract. (c) Introduction. (d) Results. (e) Discussion. (f) Materials and Methods. (g) Footnotes, including acknowledgement and abbreviation. (h) References. (i) Figure legends. (j) Tables. (k) Figures. (l) Supplementary data.
Text components of the manuscripts (a-i) should be prepared with Microsoft Word in double spacing and size 12 Times New Roman font, with all pages numbered. Tables should be prepared in Microsoft Word with single space. Figures (k) should be converted to PDF format if submitted through email (biophysics-reports@ibp.ac.cn) or uploaded individually through the online submission system (https://mc03.manuscriptcentral.com/bpr).
4. FORMAT
As we use Microsoft Word (any editions) in the Editorial office, this is the only permitted format for text. File sizes should be as small as possible, with a maximum size of 20 MB, so that they can be downloaded quickly. The combined total size of all files must not exceed 50 MB.
4.1 GENERAL FORMAT
Title The title should be informative and concise, and not longer than 150 characters (including spaces). It should describe the topic of the manuscript in terms understandable to a broad readership.
Running title The running title describes the key aspect of the paper and should be 60 characters or less (including spaces). Authors Authors should be listed with full names, beginning with the given name, and followed by the family name. Affiliations (including department/unit, institution, city, state/region, postal code and country) should be provided for each author. If the authors are affiliated to different units, the affiliation sequence should be in the same order of author list, marked at the right upper corner of the author names using 1, 2, 3, etc. Corresponding author’s name, full postal address, telephone and fax numbers and e-mail address need to be provided.
Keywords Up to 6 words separated by commas.
Abstract The abstract (up to 250 words) should be written in one paragraph, clearly indicating the objectives, the key methods, major results and their significance. Extensive experimental detail and reference should be avoided.
Introduction The introduction should include the background of the research through literature citation, the questions needed to be resolved, the objectives of the research, and the main methods used.
Results Results can be described using text, tables and figures. The text should complement material given in Tables and/or Figures but should not directly repeat it. Please give full details of statistical analysis either in the text or in Tables and/or Figure legends. Please include the type of test, the precise data to which it was applied, the value of the relevant statistics, the sample size and/or degrees of freedom, and the probability level.
Discussion The main purpose of the Discussion is to comment on the significance of the results and set them in the context of previous work. Hypothesis should be rational and evidence-based. Please avoid repeating information in the Results section. Materials and methods Methods must be described in sufficient detail to permit other laboratories to replicate experiments and verify claims. Generally, standard procedures should be referenced, though significant variations should be described. Appropriate experimental design and statistical methods should be applied and described wherever necessary for proper interpretation of data and verification of claims. All novel materials and procedures should be described in sufficient detail to allow their reproduction (e.g., DNA constructs, genetic stocks, enzyme preparations, and analytical software).
Acknowledgements A list of contributions, credits, potential conflicts of interests, and previous presentation of the information reported in the manuscript.
Abbreviations Abbreviations used in the text should be defined. However, some common names, such as GTP, RNA, PBS, PCR need not be defined. All nomenclature, including gene names and symbols, should be used in a scientifically accurate manner following the nomenclature conventions adopted by the scientific community.
Figure legends Every figure should have a title, and the figure legend should follow the title closely. Figure legends should provide enough information to make the figures understandable without frequently referring to the text. Do not describe methods in figure legends unless they are necessary to interpret the results conveyed by the figure. Define in the legend all symbols and abbreviations that are used in the figure.
Tables Tables should be self-contained and self-explanatory. All tables should be cited in the text and numbered consecutively with Arabic numerals. Label each table at the top with an Arabic numeral followed by the table title. Insert explanatory material and footnotes below the table. Designate footnotes using lowercase superscript letters (a, b, c) reading horizontally across the table. Abbreviations that are used in a table should be defined in the footnotes. Please prepare the tables in MS Word with a single-space format. Do not embed tables as graphic files, document objects, or pictures.
Figures Figures (graphs, charts, photographs, and illustrations) should be self-explanatory and labeled professionally.
Dimensional drawings and diagrams should include only the essential details and as little lettering as possible. The magnification for micrographs should be indicated by scale bars, inscriptions should be legible, and the symbols and letters should be consistent among the panels.
Please make sure that the letters, labels and symbols are in proportion to the figure and are easily readable after the figures are reduced to printable size. For example, the final text should be at least 2 mm in size and the graph lines should be at least 0.5 pt in weight. We recommend that all graphs are submitted in the intended publication size. The options include:
1 column width: 3.3 inches (8.4 cm)
2 column width: 6.7 inches (17 cm)
Maximum height: 9 inches (23.0 cm)
Figures should be prepared in a publication quality resolution. The minimal resolution is:
300 dpi for grayscale and color image
900 dpi for line art
Compliance with Ethics Guidelines In order to comply with the ethical requirements, the following sentences should be included in a separate section of each article just before the reference list. The section should be called “Compliance with Ethics Guidelines”.
Conflict of Interest:
When an author or the institution of the author has a relationship, financial or otherwise, with individuals or organizations that could influence the author’s work inappropriately, a conflict of interest may exist. Examples of potential conflicts of interest may include but are not limited to academic, personal, or political relationships; employment; consultancies or honoraria; and finical connections such as stock ownership and funding. Although an author may not feel that there are conflicts, disclosure of relationships and interests that could be viewed by others as conflicts of interest affords a more transparent and prudent process. General collective statements like “The authors declare that there is no Conflict of Interest” is NOT sufficient. The Conflict of Interest statements should list each author separately by name:
John Smith declares that he has no conflict of interest.
Paula Taylor has received research grants from Drug Company A.
Mike Schultz has received a speaker honorarium from Drug Company B and owns stock in Drug Company C.
If multiple authors declare no conflict, this can be done in one sentence:
John Smith, Paula Taylor, and Mike Schultz declare that they have no conflict of interest
For studies with human subjects include the following:
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.
If any identifying information about patients is included in the article, the following sentence should also be included:
Additional informed consent was obtained from all patients for which identifying information is included in this article.
For studies with animals include the following sentence:
All institutional and national guidelines for the care and use of laboratory animals were followed.
For articles that do not contain studies with human or animal subjects performed by any of the authors:
While it is not absolutely necessary, we recommend to include the following sentence, just to make sure that readers are aware that there are no ethical issues with human or animal subjects:
This article does not contain any studies with human or animal subjects performed by the any of the authors.
References Biophysics Reports uses EMBO J reference style in the bibliography format output. The references section should include all printed/online journal articles, books and book chapters, published conference proceedings, and meeting abstracts.
Unpublished data (including submitted manuscripts) and personal communications should be cited in text only. Please arrange the citations in alphabetical order. All authors’ names (up to ten) should be quoted. Please refer to the following examples:
 An article in a periodical:
Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS (1998) Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallographica Section D:
Biological Crystallography 54: 905-921
 An article in a book:
Jones T (1992) A set of averaging programs. In Molecular Replacement, Dodson E, Gover S, Wolf W (eds), pp 91-105. Warrington: SERC Daresbury Laboratory
 An entire book:
Gilbert, FS. (1997). Developmental Biology (Stamford: Sinauer Associates).
In the text, references should be written as in the following examples: (Gao, 2002) or (Reid et al., 2008; Rao et al., 2009) or (Levy and Little, 2007) or (Sciuto et al., 2009 a, b).
Supplementary Materials Supplementary materials that are directly related to the conclusion are welcomed. However, unrelated data may be removed by editors. Depending on the nature of the supplementary data, they can be in plain text, MS Word, MS Excel, JPEG, TIFF, video etc.. We encourage authors to submit supplementary documents in PDF format if applicable.
5. ARTICLE TYPES
5.1 PUNCTA
Puncta are essentially auto-commentary. The Editorial Board will solicit authors of the most significant recent and forthcoming papers, published elsewhere, to provide a short summary with additional insights, new interpretations or speculation on the relevant topic. The puncta should not include data, but model figures are acceptable. The first paragraph will constitute the abstract and the text is limited to 1,000 words. Puncta will have no references, but the original paper will still be noted on the first page.
5.2 METHODS
Method is a methodological report of primary research data on a new technique that is likely to be influential. Include detailed descriptions of the method, and all the technical details necessary to its reproducibility, and the results of a validation study. Show an application of the new method to an important biological question and demonstrate its advantage over existing approaches Validation of the new method and demonstration of its superiority over existing techniques most often involve novel biologically relevant data.
Begin with an unreferenced abstract and followed by separate sections for Introduction, Results, Discussion and supporting information (SI) of Methods. Introduction and Discussion are brief and focused, the Results section usually contains a general description of the method followed by its validation, and the SI section provides all technical details necessary for the independent reproduction of the methodology. The main text (excluding abstract, SI, references and figure legends) should reach 2,500 – 3,500 words.
5.3 PROTOCOLS
Protocols contain a summary, followed by separate sections comprising a brief introduction, materials, procedure (with critical steps highlighted), timing information, troubleshooting, anticipated results and references. Figures and diagrams are included, where appropriate.
5.4 REVIEWS
Authors of reviews and mini-reviews should follow the instructions above regarding abstract, font, spacing figures, tables and references. The text can be divided into sections such as “introduction” or “background” followed by section titles appropriate to the subject. The main text (excluding abstract, SI, references and figure legends) should reach 3,000 – 5,000 words.
5.5 RESEARCH ARTICLES
Original articles reporting the application of new methods that address to certain important biological questions, and results shall demonstrate the significance of new methods in comparison with existed approaches or techniques.
AFTER ACCEPTANCE
6. SUBMISSION & PUBLICATION CHARGES
6.1 ONLINE SUBMISSION
Biophysics Reports utilizes ScholarOne online submission and tracking system to provide a better, more efficient service to authors.
Authors may submit to the journal online at https://mc03.manuscriptcentral.com/bpr.
6.2 PUBLICATION CHARGES
We do not charge submission fee or publication fee. Color figures, if considered essential for comprehension of the work, will be accepted and published for free.
2015-04-17 Visited: 19215
 
CN 10-1302/Q
ISSN 2364-3439
eISSN 2364-3420
Home
About the Journal
Editorial Board
Author Guidelines
Archive
Submission
Subscription
Biophysics Reports Editorial Office
Institute of Biophysics, CAS 15 Datun Road, Chaoyang District Beijing 100101, China Tel: (86-10) 64888458
Fax: (86-10) 64889892
E-mail: biophysics-reports@ibp.ac.cn
Copyright © 2015 Biophysics Reports